1986
DOI: 10.1016/s0750-7658(86)80063-6
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacocinétique du thiopental chez la femme et le nouveau-né

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1991
1991
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…The elimination pharmacokinetics of thiopental sodium appear to be almost similar in mothers and neonates. [59,60] However, Westrin et al [61] and Jonmarker et al, [62] using an upand-down allocation technique, showed that there were marked differences in ED50 for induction between neonates, infants, and children. The curve representing ED50 versus age was very similar to the curve representing MAC versus age for halogenated agents.…”
Section: Intravenous Agentsmentioning
confidence: 99%
“…The elimination pharmacokinetics of thiopental sodium appear to be almost similar in mothers and neonates. [59,60] However, Westrin et al [61] and Jonmarker et al, [62] using an upand-down allocation technique, showed that there were marked differences in ED50 for induction between neonates, infants, and children. The curve representing ED50 versus age was very similar to the curve representing MAC versus age for halogenated agents.…”
Section: Intravenous Agentsmentioning
confidence: 99%
“…Pharmacokinetic studies of this agent in patients undergoing caesarean section have shown some conflicting results, partly because of differences in modelling technique and sam piing regimens (table I) [Christensen et al 1981;Monrigal et al 1986;Morgan et al 1981]. Hepatic metabolism of thiopental is capacity limited and the increased clearance during pregnancy may be a result of hormonal enzyme induction.…”
Section: Thiopentalmentioning
confidence: 99%